Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vaccines, Subunit | 3 | 2020 | 1088 | 0.79 | Why? |
| Immunoconjugates | 1 | 2018 | 90 | 0.68 | Why? |
| Viral Structural Proteins | 1 | 2020 | 491 | 0.64 | Why? |
| Herpesvirus 1, Human | 1 | 2019 | 286 | 0.62 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2019 | 415 | 0.54 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2020 | 1267 | 0.50 | Why? |
| Hydrodynamics | 1 | 2013 | 177 | 0.49 | Why? |
| Epitopes, T-Lymphocyte | 3 | 2020 | 2262 | 0.49 | Why? |
| Drug Delivery Systems | 3 | 2021 | 1365 | 0.48 | Why? |
| Coronary Circulation | 1 | 2013 | 188 | 0.46 | Why? |
| Ribonucleotide Reductases | 2 | 2019 | 3 | 0.40 | Why? |
| MicroRNAs | 1 | 2021 | 1787 | 0.35 | Why? |
| Escherichia coli | 3 | 2020 | 1547 | 0.34 | Why? |
| Epitopes | 1 | 2019 | 4113 | 0.31 | Why? |
| Molecular Docking Simulation | 6 | 2021 | 6902 | 0.30 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.28 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.24 | Why? |
| Influenza in Birds | 2 | 2018 | 528 | 0.24 | Why? |
| Flavobacteriaceae | 2 | 2019 | 12 | 0.24 | Why? |
| Water Resources | 1 | 2021 | 14 | 0.23 | Why? |
| Waste Disposal Facilities | 1 | 2021 | 57 | 0.23 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.23 | Why? |
| Nanocapsules | 1 | 2021 | 54 | 0.21 | Why? |
| Norwalk virus | 1 | 2019 | 2 | 0.21 | Why? |
| Protein Conformation | 3 | 2020 | 4386 | 0.21 | Why? |
| Handwriting | 1 | 2018 | 5 | 0.20 | Why? |
| Vaccines, Combined | 1 | 2019 | 67 | 0.19 | Why? |
| Manganese | 1 | 2019 | 111 | 0.19 | Why? |
| Models, Molecular | 4 | 2020 | 7616 | 0.18 | Why? |
| Drug Stability | 1 | 2019 | 236 | 0.18 | Why? |
| Arachidonate 12-Lipoxygenase | 1 | 2017 | 15 | 0.18 | Why? |
| Water Purification | 1 | 2021 | 285 | 0.18 | Why? |
| Moringa oleifera | 1 | 2017 | 22 | 0.17 | Why? |
| Pattern Recognition, Automated | 1 | 2018 | 160 | 0.17 | Why? |
| Glycoside Hydrolases | 1 | 2017 | 44 | 0.17 | Why? |
| Molecular Dynamics Simulation | 2 | 2021 | 4155 | 0.17 | Why? |
| Animal Husbandry | 1 | 2017 | 162 | 0.16 | Why? |
| Zebrafish | 1 | 2017 | 181 | 0.16 | Why? |
| Models, Biological | 1 | 2013 | 4907 | 0.16 | Why? |
| Capsid Proteins | 1 | 2019 | 365 | 0.16 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.15 | Why? |
| Protein Subunits | 1 | 2018 | 755 | 0.14 | Why? |
| Drug Carriers | 1 | 2021 | 590 | 0.14 | Why? |
| Elasticity | 1 | 2013 | 70 | 0.14 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.13 | Why? |
| Extracellular Vesicles | 1 | 2021 | 607 | 0.13 | Why? |
| Stress, Mechanical | 1 | 2013 | 143 | 0.13 | Why? |
| Drug Repositioning | 3 | 2021 | 5683 | 0.13 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.13 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.12 | Why? |
| Calcium | 1 | 2017 | 708 | 0.12 | Why? |
| Animals | 10 | 2021 | 78931 | 0.11 | Why? |
| Coronary Stenosis | 1 | 2013 | 273 | 0.10 | Why? |
| Hygiene | 1 | 2017 | 987 | 0.10 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.10 | Why? |
| Influenza A virus | 2 | 2018 | 2234 | 0.10 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.09 | Why? |
| Computer Simulation | 2 | 2021 | 4982 | 0.09 | Why? |
| Bangladesh | 3 | 2020 | 1620 | 0.09 | Why? |
| Gene Expression | 1 | 2019 | 3332 | 0.09 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.09 | Why? |
| Ducks | 2 | 2018 | 120 | 0.09 | Why? |
| Computational Biology | 2 | 2020 | 4514 | 0.08 | Why? |
| Evolution, Molecular | 1 | 2020 | 3691 | 0.08 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.08 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.08 | Why? |
| Coronary Vessels | 1 | 2013 | 914 | 0.08 | Why? |
| Vaccines, Synthetic | 1 | 2019 | 3231 | 0.08 | Why? |
| Plant Extracts | 1 | 2017 | 1514 | 0.08 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Humans | 19 | 2021 | 930598 | 0.06 | Why? |
| Viral Vaccines | 2 | 2021 | 7560 | 0.06 | Why? |
| Chickens | 2 | 2018 | 1010 | 0.06 | Why? |
| Rifabutin | 1 | 2020 | 20 | 0.06 | Why? |
| Crystallography, X-Ray | 2 | 2019 | 2689 | 0.05 | Why? |
| Aerococcaceae | 1 | 2019 | 1 | 0.05 | Why? |
| Electron Spin Resonance Spectroscopy | 1 | 2019 | 14 | 0.05 | Why? |
| Superoxides | 1 | 2019 | 36 | 0.05 | Why? |
| Free Radicals | 1 | 2019 | 55 | 0.05 | Why? |
| Toll-Like Receptor 8 | 1 | 2019 | 102 | 0.05 | Why? |
| Nucleoproteins | 1 | 2020 | 223 | 0.05 | Why? |
| Rats, Long-Evans | 1 | 2017 | 3 | 0.05 | Why? |
| Rifampin | 1 | 2020 | 276 | 0.04 | Why? |
| Allosteric Regulation | 1 | 2018 | 134 | 0.04 | Why? |
| Intestinal Absorption | 1 | 2017 | 64 | 0.04 | Why? |
| Amino Acid Sequence | 2 | 2020 | 6049 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2019 | 540 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Binding Sites | 2 | 2020 | 6201 | 0.04 | Why? |
| Alphacoronavirus | 1 | 2020 | 392 | 0.04 | Why? |
| Poultry | 1 | 2017 | 437 | 0.04 | Why? |
| Metagenomics | 1 | 2021 | 823 | 0.03 | Why? |
| Nanotechnology | 1 | 2021 | 821 | 0.03 | Why? |
| Sequence Homology, Amino Acid | 1 | 2017 | 945 | 0.03 | Why? |
| Coronavirus NL63, Human | 1 | 2020 | 669 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2019 | 680 | 0.03 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.03 | Why? |
| Environmental Microbiology | 1 | 2018 | 575 | 0.03 | Why? |
| Nanostructures | 1 | 2021 | 700 | 0.03 | Why? |
| HLA Antigens | 1 | 2019 | 830 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Protein Structure, Tertiary | 1 | 2017 | 1565 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2020 | 1157 | 0.03 | Why? |
| Protein Multimerization | 1 | 2018 | 1336 | 0.03 | Why? |
| Coronavirus 229E, Human | 1 | 2020 | 1241 | 0.03 | Why? |
| Ivermectin | 1 | 2020 | 973 | 0.03 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| Brain | 1 | 2021 | 5133 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.02 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
Hasan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(115)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_